nach oben

Current Infectious Disease Reports

Erschienen in:

01.08.2011

Vascular Access Infections: Epidemiology, Diagnosis, and Management

verfasst von: Jacob A. Akoh

Erschienen in: Current Infectious Disease Reports | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Infection is the most challenging and life-threatening complication of vascular access and causes significant morbidity, loss of access, and mortality. The aims of this review are to determine the magnitude of the infection problem, identify possible factors, and provide an update on the management of vascular access infections. Infections account for approximately 15% to 36% of all deaths in dialysis patients (the second leading cause after cardiovascular events) and for about 20% of admissions. Several studies demonstrate a hierarchy of infection risk from temporary catheter, tunnelled cuffed catheter, arteriovenous grafts, to arteriovenous fistula in decreasing order. Suspicion of infection must be followed by appropriate blood cultures, including possible simultaneous sampling from a peripheral vein and the access. The best way to treat vascular access infection is prevention, bearing in mind the idea “fistula first” and “lines last”, with the appropriate use of arteriovenous grafts and newer devices sandwiched in between.

Lok CE. Firstula first initiative: advantages and pitfalls. Clin J Am Soc Nephrol. 2007;2:1043–53.PubMedCrossRef

Lemaire X, Morena M, Leray-Moragués H, et al. Analysis of risk factors for catheter-related bacteremia in 2000 permanent dual catheters for haemodialysis. Blood Purif. 2009;28:21–8.PubMedCrossRef

• Li Y, Friedman JY, O'Neal BF, et al.: Outcomes of Staphylococcus aureus infection in haemodialysis-dependent patients. Clin J Am Soc Nephrol 2009, 4: 428–34. This article highlights the clinical and economic burdens of vascular access infection.

Akoh JA, Riaz M. Management of patients with challenging vascular access needs. Int Surg. 2009;94:95–8.PubMed

Schutte WP, Helmer SD, Salazar L, Smith JL. Surgical treatment of infected prosthetic dialysis arteriovenous grafts: total versus partial graft excision. Am J Surg. 2007;193:385–8.PubMedCrossRef

Englesbe MJ, Al-Holou WN, Moyer AT, et al. Single centre review of femoral arteriovenous grafts for haemodialysis. World J Surg. 2006;30:171–5.PubMedCrossRef

Ryan SV, Calligaro KD, Scharff J, Dougherty MJ. Management of infected prosthetic dialysis arteriovenous grafts. J Vasc Surg. 2004;39:73–8.PubMedCrossRef

Foley RN, Guo H, Snyder JJ, et al. Septicaemia in the United States dialysis population. J Am Soc Nephrol. 2004;15:1038–45.PubMedCrossRef

Barraclough KA, Hawley CM, Playford EG, Johnson DW. Prevention of access-related infection in dialysis. Expert Rev Anti Infect Ther. 2009;7:1185–200.PubMedCrossRef

10.

• Millar MR, Johnson G, Wilks M, et al.: Molecular diagnosis of vascular access device-associated infection in children being treated for cancer or leukaemia. Clinic Microbiol Infect 2008, 14: 213–20. This article describes a new test able to predict likelihood of VAD survival. The study was performed by laboratory staff working at distant site who were unaware of the clinical details of individual patients. Test results are available within a few hours, providing the potential for early specific intervention for VAD infection.

11.

NKF-KDOQI Clinical guidelines for vascular access. Am J Kidney Dis 2006, 48: S177-S276.

12.

Lafrance JP, Rahme E, Lelorier J, Iqbal S. Vascular access-related infections: definitions, incidence rates, and risk factors. Am J Kidney Dis. 2008;52:982–93.PubMedCrossRef

13.

Ponce P, Cruz J, Ferreira A, et al. A prospective study on incidence of bacterial infections in portuguese dialysis units. Nephron. 2007;107:c133–8.PubMed

14.

Saeed Abdulrahman I, Al-Mueilo SH, Bokhary HA, et al.: A prospective study of haemodialysis access-related bacterial infections. J Infect Chemotherapy 2002, 8: 242–6.

15.

Mokrzycki MH, Zhang M, Cohen H, et al. Tunnelled haemodialysis catheter bacteraemia: risk factors for bacteraemia recurrence, infectious complications and mortality. Nephrol Dial Transplant. 2006;21:1024–31.PubMedCrossRef

16.

Tokars JI, Miller ER, Stein G. New national surveillance system for haemodialysis-associated infections: initial results. Am J Infect Control. 2002;30:288–95.PubMedCrossRef

17.

• Rodríguez-Aranda A, Alcazar JM, Sanz F, et al.: Endoluminal colonization as a risk factor for coagulase-negative staphylococcal catheter-related bloodstream infections in haemodialysis patients. Nephrol Dial Transplant. 2010 Aug 11. [Epub ahead of print]. This article looks at a readily available method to predict risk of catheter-related bloodstream infection.

18.

Alexandraki I, Sullivan R, Zaiden R, et al. Blood culture isolates in haemodialysis vascular catheter-related bacteremia. Am J Medical Sciences. 2008;336:297–302.CrossRef

19.

Sychev D, Maya ID, Allon M. Clinical outcomes of dialysis catheter-related candidemia in haemodialysis patients. Clin J Am Soc Nephrol. 2009;4:1102–5.PubMedCrossRef

20.

Taylor G, Gravel D, Johnston L, et al. Canadian Hospital Epidemiology Committee. Canadian Nosocomial Infection Surveillance Program. Prospective surveillance for primary bloodstream infections occurring in Canadian haemodialysis units. Infect Control Hospital Epidemiol. 2002;23:716–20.CrossRef

21.

Stevenson KB, Hannah EL, Lowder CA, et al. Epidemiology of haemodialysis vascular access infections from longitudinal infection surveillance data: predicting the impact of NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis. 2002;39:549–55.PubMedCrossRef

22.

Wasse H. Catheter-related mortality among ESRD patients. Semin Dial. 2008;21:547–9.PubMedCrossRef

23.

Colville LA, Lee AH. Retrospective analysis of catheter-related infections in a haemodialysis unit. Infect Control Hospl Epidemiol. 2006;27:969–73.CrossRef

24.

Collins AJ, Foley RN, Gilbertson DT, Chen SC. The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis. Clin J Am Soc Nephrol. 2009;4:S5–11.PubMedCrossRef

25.

Rehman R, Schmidt RJ, Moss AH. Ethical and legal obligation to avoid long-term tunneled catheter access. Clin J Am Soc Nephrol. 2009;4:456–60.PubMedCrossRef

26.

Yildizeli B, Lacin T, Batirel HF, Yuksel M. Complications and management of long-term central venous access catheters and ports. J Vasc Access. 2004;5:174–8.PubMed

27.

Dendle C, Martin RD, Cameron DR, et al. Staphylococcus aureus bacteraemia as a quality indicator for hospital infection control. Med J Aust. 2009;191:389–92.PubMed

28.

Churchill DN, Taylor DW, Cook RJ, et al. Canadian Haemodialysis morbidity study. Am J Kidney Dis. 1992;19:214–34.PubMed

29.

Schild AF, Simon S, Prieto J, Raines J. Single-centre review of infections associated with 1574 consecutive vascular access procedures. Vasc Endovasc Surg. 2003;37:27–31.CrossRef

30.

Akoh JA, Patel N. Infection of haemodialysis arteriovenous grafts. J Vasc Access. 2010;11:155–8.PubMed

31.

Salimi J. Patency rate and complications of vascular access grafts for haemodialysis in lower extremities. Saudi J Kidney Dis Transplant. 2008;19:929–32.

32.

Antoniou GA, Lazarides MK, Georgiadis GS, et al. Lower-extremity arteriovenous access for haemodialysis: a systematic review. Eur J Vasc Endovasc Surg. 2009;38:365–72.PubMedCrossRef

33.

Geenen IL, Nyilas L, Stephen MS, et al.: Prosthetic lower extremity haemodialysis access grafts have satisfactory patency despite a high incidence of infection. J Vasc Surg 2010 Aug 21. [Epub ahead of print]

34.

Abreo KD, Ram SJ. Thigh grafts: a preferable alternative to catheters when upper extremity access sites are exhausted. Semin Dial. 2009;22:469–71.PubMedCrossRef

35.

Tokars JI, Light P, Anderson J, et al. A prospective study of vascular access infections at seven outpatient haemodialysis centres. Am J Kidney Dis. 2001;37:1232–40.PubMedCrossRef

36.

• Lafrance JP, Iqbal S, Lelorier J, et al.: Vascular access-related bloodstream infections in First Nations, community and teaching Canadian dialysis units, and other centre-level predictors. Nephron Clin Pract. 2010, 114: c204-12. This retrospective cohort study includes various types of dialysis centers, which makes the findings generalizable to the entire population. Center level risks of bloodstream infection are not significantly different.

37.

• Reddy S, Sullivan R, Zaiden R, et al.: Hepatitis C infection and the risk of bacteremia in haemodialysis patients with tunneled vascular access catheters. South Med J. 2009, 102: 374–7. This article shows that HCV patients with detectable virus are at increased risk of CVC-related bacteremia.

38.

Salman L, Asif A. Antibiotic prophylaxis: is it needed for dialysis access procedures? Semin Dial. 2009;22:297–9.PubMedCrossRef

39.

van Loon MM, Goovaerts T, Kessels AG, et al. Buttonhole needling of haemodialysis arteriovenous fistulae results in less complications and interventions compared to the rope-ladder technique. Nephrol Dial Transplant. 2010;25:225–30.PubMedCrossRef

40.

Troidle L, Eisen T, Pacelli L, Finkelstein F. Complications associated with the development of bacteraemia with Staphylococcus aureus. Haemodialysis Int. 2007;11:72–5.

41.

Desai M, Rapoor R, Gudithi SL, et al. Endophthalmitis: a rare complication of arteriovenous fistula infection. Haemodialysis Int. 2008;12:227–9.CrossRef

42.

Fernandez-Cean J, Alvarez A, Burguez S, et al. Infective endocarditis in chronic haemodialysis: two treatment strategies. Nephrol Dial Transplant. 2002;17:2226–30.PubMedCrossRef

43.

•• Mermel LA, Allon M, Bouza E, et al.: Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 2009, 49: 1–45. These are comprehensive clinical practice guidelines for management of CVC/VAD-related infection. Analysis of data published from 2001 to 2008 was used to update the 2001 guidelines. The guidelines were written by an expert panel with widespread representation from America and Europe.

44.

Raad I, Hanna H, Maki D. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect Dis. 2007;7:645–57.PubMedCrossRef

45.

Higgins M, Evans DS. Nurses' knowledge and practice of vascular access infection control in haemodialysis patients in the Republic of Ireland. J Renal Care. 2008;34:48–53.CrossRef

46.

Easterlow D, Hoddinott P, Harrison S. Implementing and standardising the use of peripheral vascular access devices. J Clinic Nursing. 2010;19:721–7.CrossRef

47.

Patel PR, Kallen AJ, Arduino MJ. Epidemiology, surveillance, and prevention of bloodstream infections in haemodialysis patients. Am J Kidney Dis. 2010;56:566–77.PubMedCrossRef

48.

• Rabindranath KS, Bansal T, Adams J, et al.: Systematic review of antimicrobials for the prevention of haemodialysis catheter-related infections. Nephrol Dial Transplant. 2009; 24: 3763–74. This article is a systematic review of 29 trials involving 3005 catheters in 2886 patients showing antimicrobial locks and exit site antimicrobials reduce CVC infections.

49.

Tercier S, Gapany C, Diezi M, et al. Incidents and complications of totally implanted vascular access devices in children: a prospective study. Patient Saf Surg. 2008;2:30.PubMedCrossRef

50.

• Katzman HE, McLafferty RB, Ross JR, et al.: Initial experience and outcome of a new haemodialysis access device for catheter-dependent patients. J Vasc Surg 2009; 50: 600–7, 607.e1. This article describes a new device for ensuring access in patients with central venous obstruction.

Titel: Vascular Access Infections: Epidemiology, Diagnosis, and Management
verfasst von: Jacob A. Akoh
Publikationsdatum: 01.08.2011
Verlag: Current Science Inc.
Erschienen in: Current Infectious Disease Reports / Ausgabe 4/2011
Print ISSN: 1523-3847
Elektronische ISSN: 1534-3146
DOI: https://doi.org/10.1007/s11908-011-0192-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2011

The Changing Landscape of Progressive Multifocal Leukoencephalopathy

Do Delays in Performing Lumbar Puncture After Administration of Antibiotics Alter the Results of CSF Cultures?

Synergy: A Cautionary Tale

Cardiovascular Implantable Device Infections

Meningococcal Disease: Shifting Epidemiology and Genetic Mechanisms That May Contribute to Serogroup C Virulence